Crit Rev Ther Drug Carrier Syst. 2020;37(2):135-159. doi: 10.1615/CritRevTherDrugCarrierSyst.2020029259.
PMID:32865903
Nail Psoriasis in Older Adults: Epidemiology, Diagnosis, and Topical Therapy.
Ricardo JW, Lipner SR.
Dermatol Clin. 2021 Apr;39(2):183-193. doi: 10.1016/j.det.2020.12.011. Epub 2021 Feb 11.
PMID:33745632
Dermoscopic features of nail psoriasis: a systematic review.
Rachadi H, Chiheb S.
Int J Dermatol. 2024 Aug;63(8):1013-1019. doi: 10.1111/ijd.17138. Epub 2024 Mar 22.
PMID:38520074
Nail Psoriasis in Older Adults: Intralesional, Systemic, and Biological Therapy.
Ricardo JW, Lipner SR.
Dermatol Clin. 2021 Apr;39(2):195-210. doi: 10.1016/j.det.2020.12.012. Epub 2021 Feb 10.
PMID:33745633
Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI).
Mease PJ.
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S64-85. doi: 10.1002/acr.20577.
PMID:22588772
Updates in treatment and impact of nail psoriasis.